11.100
−0,89%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +3.2% | +668.0% | 2 / 3 | +4.2% | -2.47 pp | -0.35 pp | +0.6% | 0.00 | 118.21 | 870 | +4,2% | 27,9 | −6,1% | 118.21 | 23.79 | +396,9% |
| Pts | 0 | 12 | 8 | 0 | 4 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 11.100 (close price on 2026-10-19)EPS (TTM): 93,9
Financial charts
1.Revenue & growth
VND bn870Q2/26
1.Revenue & growth
VND bn870Q2/26
2.Profit & growth
VND bn15,4Q2/26
3.Profit mix (Penman)
VND bn73,8Q2/26
4.Margins & cost structure
%21.5%Q2/26
5.Returns & cash cycle
% · days-2.5%Q2/26
6.Earnings quality & cash
VND bn-182Q2/26
7.Asset structure
VND bn6.574Q2/26
8.Funding & debt health
VND bn · times6.574Q2/26
9.Revenue backlog
VND bn13,9Q2/26
10.Valuation
times · %118,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %73Q2/26
Adjusted EPS growth, latest quarter
3.2%
Average adjusted EPS growth, 3 quarters
668%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26